CVS Health Corp
Research CVS Health Corp (CVS) on Bullrun: valuation model: 27.4% overvalued, market cap USD 118.73B, P/E 24.5, dividend yield 2.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCVS
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryHealthcare Plans
- CurrencyUSD
- Valuation signal27.4% overvalued
- Market capUSD 118.73B
- P/E24.5
- Dividend yield2.9%
- Financial periodQ2 2026
- RevenueUSD 106.10B
- Net incomeUSD 2.98B
- Free cash flowUSD 5.65B
- Gross margin14.8%
Valuation Snapshot
Bullrun's latest valuation model marks CVS Health Corp as 27.4% overvalued; latest market cap is USD 118.73B; P/E is 24.5; dividend yield is 2.9%.
Peer valuation comparison
Latest P/E is 24.53x versus a Healthcare sector median of 24.46x.
Latest dividend yield is 2.87% versus a Healthcare sector median of 2.11% (36.0% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 402.07B | USD 1.77B | USD 7.81B | 45.0% | 1.39 | USD 8.45B | USD 0 | USD 75.21B |
| FY2024 | USD 372.81B | USD 4.61B | USD 6.33B | 44.7% | 3.66 | USD 8.59B | USD 2.12B | USD 75.56B |
| FY2023 | USD 357.78B | USD 8.34B | USD 10.40B | 39.3% | 6.47 | USD 8.20B | USD 200.00M | USD 76.46B |
| FY2022 | USD 322.47B | USD 4.31B | USD 13.45B | 38.9% | 3.26 | USD 12.95B | USD 0 | USD 71.47B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 118.73B | 24.5 | 2.9% | 2.67 |
| 2025 | 2025-12-31 | USD 100.87B | 57.5 | 3.4% | 2.68 |
| 2024 | 2024-12-31 | USD 56.56B | 12.3 | 6.0% | 2.68 |
| 2023 | 2023-12-29 | USD 101.61B | 11.9 | 3.1% | 2.44 |
| 2022 | 2022-12-30 | USD 122.45B | 37.9 | 2.4% | 2.2 |
| 2021 | 2021-12-31 | USD 136.38B | 17.3 | 1.9% | 2 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.67 USD, yield 2.9%.
| Year | Dividends/share |
|---|---|
| FY2025 | 2.66 USD |
| FY2024 | 2.66 USD |
| FY2023 | 2.42 USD |
| FY2022 | 2.2 USD |
About CVS Health Corp
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is CVS Health Corp overvalued or undervalued?
Bullrun's valuation model currently marks CVS Health Corp as 27.4% overvalued.
What is CVS Health Corp's market cap?
CVS Health Corp's market capitalization is USD 118.73B.
What is CVS Health Corp's P/E ratio?
CVS Health Corp's price-to-earnings (P/E) ratio is 24.5.
Does CVS Health Corp pay a dividend?
CVS Health Corp has a dividend yield of 2.9%.
What does CVS Health Corp do?
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services.